Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Vincerx Pharma, Inc. VINC

Full chart Compare
Set alert

Price alert · VINC

All alert types
0.01 USD 0.00 (+0.00%)

At closeFeb 5, 2026, 4:00 PM EST

0.06 +0.05 +391.54%

After hours · Feb 5, 4:00 PM ET

0.0053 Day range 0.0053
0.005 52-week range 0.026
YTD
0.00%
1 year
-75.00%

Financial health

Altman Z-Score

-76.48 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.9×
FY 2019: -5955×FY 2020: -35.8×FY 2021: -24.6×FY 2022: -1.9×FY 2023: -3.5×FY 2024: -0.9×
FY 2019 5y median -3.5× FY 2024
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024
P/B 10.1×
FY 2019: -6090×FY 2020: 23.5×FY 2021: 9.6×FY 2022: 2.5×FY 2023: 12.4×FY 2024: 10.1×
FY 2019 5y median 10.1× FY 2024
P/FCF -1.1×
FY 2019: -7656×FY 2020: -261×FY 2021: -25.0×FY 2022: -2.0×FY 2023: -3.4×FY 2024: -1.1×
FY 2019 5y median -3.4× FY 2024
EV/EBITDA -0.7×
FY 2019: 29697×FY 2020: -33.7×FY 2021: -22.0×FY 2022: -1.8×FY 2023: -3.3×FY 2024: -0.7×
FY 2019 5y median -3.3× FY 2024
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024
FCF Yield -94.9%
FY 2019: -0.0%FY 2020: -0.4%FY 2021: -4.0%FY 2022: -50.4%FY 2023: -29.2%FY 2024: -94.9%
FY 2019 5y median -29.2% FY 2024

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
ROE -1104.0%
FY 2019: 122.7%FY 2020: -65.5%FY 2021: -39.2%FY 2022: -137.1%FY 2023: -357.8%FY 2024: -1104.0%
FY 2019 5y median -137.1% FY 2024
ROIC -1155.0%
FY 2019: -6.0%FY 2020: -42.2%FY 2021: -60.0%FY 2022: -134.3%FY 2023: -309.3%FY 2024: -1155.0%
FY 2019 5y median -134.3% FY 2024
ROA -375.7%
FY 2019: -5400.0%FY 2020: -26.3%FY 2021: -33.4%FY 2022: -110.3%FY 2023: -220.4%FY 2024: -375.7%
FY 2019 5y median -110.3% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 FY 2024
Operating Income 26.2%
FY 2019: 0.0%FY 2020: -23708.9%FY 2021: -484.8%FY 2022: -9.7%FY 2023: 38.0%FY 2024: 26.2%
FY 2019 FY 2024
EPS (diluted) 15.9%
FY 2019: 0.0%FY 2020: -37065.6%FY 2021: 28.9%FY 2022: -30.8%FY 2023: 37.0%FY 2024: 15.9%
FY 2019 FY 2024
Free Cash Flow 35.4%
FY 2019: 0.0%FY 2020: -6411.7%FY 2021: -1596.4%FY 2022: -54.2%FY 2023: 32.1%FY 2024: 35.4%
FY 2019 FY 2024

Financial Health

Current Ratio 1.2×
FY 2019: 18.0×FY 2020: 1.7×FY 2021: 8.0×FY 2022: 6.1×FY 2023: 2.6×FY 2024: 1.2×
FY 2019 5y median 2.6× FY 2024
Quick Ratio 1.2×
FY 2019: 18.0×FY 2020: 1.7×FY 2021: 8.0×FY 2022: 6.1×FY 2023: 2.6×FY 2024: 1.2×
FY 2019 5y median 2.6× FY 2024
Debt / Equity 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024
Net Debt / EBITDA 0.2×
FY 2019: -76.1×FY 2020: 3.9×FY 2021: 2.8×FY 2022: 0.1×FY 2023: 0.3×FY 2024: 0.2×
FY 2019 5y median 0.3× FY 2024
Interest Coverage 0.0×
FY 2019: 0.0×FY 2020: -1339×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31